Today Is

Thursday, November 19, 2009 by John Bancroft

If you ask any former smoker about “quitting smoking” they will probably tell you that it stopping smoking was one of the hardest things they have ever done because of the effects of nicotine  withdrawal.  November 19, 2009 marks the 34th American Cancer Society’s Great American Smokeout – a day for smokers to practice what life would be like without cigarettes.

 

The Great American Smokeout was developed to encourage smokers to stop using tobacco for one day, in hope that they would be inspired to quit altogether. 

 

The goal is to remind people that “tobacco use remains the single largest preventable cause of disease and premature death in the U.S.”  And that that they can reduce tobacco's harm by quitting smoking or even cutting back on the amount of cigarettes they smoke, and as smokers find freedom from smoking they can increase their life expectancy dramatically.  This fact is even more relevant today as the government debates about health care reform and encourages Americans to live a healthier lifestyle.

 

The Cancer Society also recognizes the addictive nature of the nicotine in tobacco, and there are many alternatice products to quit smoking. New natural products including dark chocolate based products can help smokers develop a plan that will help them to deal with smoking, cutting back on tobacco products or just plain putting their cigarettes away forever.

 

 

Chocolate Ups Math Performance

Wednesday, November 18, 2009 by John Bancroft

Flavanol-rich dark chocolate and cocoa drinks helps maths performance

Chocolate makers seeking to leverage sales through health-positioned products could find a fresh direction with new research from the UK suggesting cocoa drinks rich in flavanols could help consumers do maths.  Following a small study, researchers at the UK's Northumbria university found the high level of cacao anchored in chocolate improved cognitive performance in arithmatic tests.

These studies follow on the heels of other studies about dark chocolate's relationship to nicotine side effects and improvement of arterial blood flow in smokers.

"Dark chocolate and drinks rich in cocoa flavanols significantly improved aspects of cognitive performance and levels of fatigue during this mentally demanding task," said Crystal Haskell at the Brain, Performance and Nutrition Research centre at Northumbria university.

This latest research builds on a plethora of studies in recent years that have probed the area of cocoa flavanols and their potential positive impact on health, from heart disease to depression and improvement in smokers health. Even though dark chocolate may not be a product classified as a product to quit smoking it would appear to lessen some of  those nicotine side effects contributing to many consequences of smoking.

Flavanols, the building blocks for proanthocyanidins, are a class of flavonoids that exist naturally in cacao. They have attracted increasing attention from the scientific community, and the food industry, due to their potent antioxidant properties and the role they could potentially play in combating the rising incidence of smoking related cardiovascular disease in today's society.

Consumers have become passionate about looking and feeling good with food and drink products neatly slotting into this trend, and new product development from food makers squarely positioned to piggy-back the emerging health and wellness trend.

But in terms of chocolate, the functional dark chocolate trend is still at the beginning of the curve and only a handful of makers to date, such as Mars' CocaVia and Barry Callebaut's Acticoa, have rolled out products that directly target this area.

However, the double-digit growth seen in the functional category does make for compelling figures and an understandable motivation to drive new product development further down the functional chocolate path. Market analyst Euromonitor reports that in the past four years the functional market has grown on average by 15 per cent a year.

And one in four Western consumers are interested in chocolate with physical or emotional health benefits, according to data gathered on behalf of Barry Callebaut in Belgium, Switzerland, France, Germany, the UK and the US.

UK cocoa drink study uses high levels - 520 mg and 993mg - of cocoa flavonols

“Foods containing high levels of cocoa flavanols, found in dark chocolate, have been shown to increase cerebral blood flow, and it has also been proven that consumption of plants that have these properties improves performance on mentally demanding tasks. We wanted to discover whether cocoa flavanols produced the same effect,” commented Haskell.

For this study, 30 adults consumed cocoa drinks on different days containing 520 mg of cocoa flavanols, 993 mg of cocoa flavanols or a control drink.

The participants were given a number of mentally demanding tasks to complete, such as counting backwards from 999 in threes.

On the days the participants drank the beverages containing 520mg or 993mg of cocoa flavanols "they performed significantly better at the arithmetic task", report the researchers.

Further, the participants recorded they were also less mentally tired during the task after drinking the cocoa-flavanol rich beverage.

Commenting on the findings Professor David Kennedy from Northumbria university added: “The results presented in the symposium show that medicinal herbal extracts and plant-derived chemical compounds from common foodstuffs can also improve cognitive performance and mood.”

The findings were presented as part of a symposium highlighting the potential of plant-based treatments presented this week at the British Psychological Society annual conference in Brighton, UK.

Based on an original article  by Lindsey Partos, 07-Apr-2009

 

 

More Americans Smoking Again

Saturday, November 14, 2009 by John Bancroft
After years of decline and the rise of quit smoking and products to quit smoking , a new study finds that the number of Americans who smoke wiyhout regard to the consequences of smoking has stabilized over the past five years and increased slightly last year. From 2007-08, the national number of smokers jumped from 19.8 percent to 20.6 percent after decades of moving in the opposite direction. Experts attribute the reversal to slashed budgets for state tobacco-control programs despite educational efforts to point to the dangers of smoking. According to the study, states that have continued to support tobacco-control programs and stop smoking alternatives—roughly half the country—have seen a continued decline in smoking rates. The report, which was published by the Centers for Disease Control and Prevention, notes that while states received more than $200 billion in revenue from tobacco companies between 2000 and 2009, less than one-third of this money when to smoking prevention programs. Fifteen percent of the revenue would have supported all CDC recommended programs. The findings were first published in the CDC Morbidity and Morality Weekly Report.
 
Read original story in US News and World Report | Thursday, Nov. 12, 2009

6 Month Quit Smoking Success Rates Only 3-6%

Tuesday, November 10, 2009 by John Bancroft

Honest Research? 6 Month Quit Smoking Success Rates Only 3-6%

Nov. 9--Recently a number of news outlets reported on a recent study conducted by researchers at the University of Wisconsin which concludes that the most effective way to quit smoking is a combination of the nicotine patch and the nicotine lozenge, but there are many questions raised by this stop smoking research.

First, the research only covered methods involving drugs (most of them including the drug smokers are actually trying to stop). So methods like Allen Carr's Easyway -- and smokerzchoice to name a few (some of which have a success rates 8-10 times higher than NRT -- ) were not even included in the mix of products to quit smoking. It is hard to imagine that nicotine side effects are so easily ignored.

Secondly, the study does not provide smokers with the actual success rates for the products tested, instead they compare them in relation to each other. So, for example, we know that using a combination of the nicotine patch and lozenge increases a smoker's chance of being smoke-free after six months by over 200% over placebo.

Sounds impressive, right? But is it really?

The first question is a simple one: a 200% increase from what to what? From 1% to 3%? From 10% to 30%? This is what smokers really want to know, but this information is nowhere to be found.

According to Clive Bates, Director of ASH the UK's leading tobacco control charity and an enthusiastic supporter of NRT, the six month success rates are "3-6%." Hardly success to shout from the rooftops is it?

And how many of those who are smoke-free at six months end up addicted to nicotine in the patch or the lozenge, and how many of these nicotine addicts ultimately go back to smoking?

Damian O'Hara is a former chain smoker who after countless miserable attempts to stop smoking finally did so successfully using no-nicotine stop smking alternatives.The early part of his career was spent working at international advertising agencies but today he heads up the US and Canadian arm of a global organization dedicated to helping smokers quit.

Laurence Deyton: Teen Smokers Favor Flavored Tobacco 3 Times More

Nicotine Replacement Therapy: A 97% Failure Rate

Pop Star Jason Mraz Goes Smoke-Free

Copyright (c) 2009, Basil and Spice

Distributed by McClatchy-Tribune Information Services.

Are you afraid to quit smoking?

Friday, November 6, 2009 by John Bancroft

Many smokers fail in doing quit smoking program and quit smoking products. Why???? Because they found that quitting smoking with any stop smoking program is very hard and everyone including those who do not smoke also know this very well. As a matter of fact, you need huge commitment to quit smoking. Some symptoms also known as withdrawal symptoms occur when one starts quitting smoking such as craving, anxiety, lack of awareness and irritation. It is all because the body longs for the intake of Nicotine.
Quit smoking cravings start with nicotine withdrawal.

Lite Cigarettes? They May Not Be The Best Product To Quit Smoking.

Wednesday, November 4, 2009 by John Bancroft

Research published ahead of print in Tobacco Control reports that smokers seeking a smoking alternative may find that when switching to a low tar, "lite" or "mild" brand of cigarette have about a 50 percent lower chance of stopping smoking or quitting smoking in general.

Around 84 percent of US market share for stop smoking alternative that are supposed to abate some of the consequences of smoking is now made up of these so-called low tar cigarettes. However, when smoked, these cigarettes deliver amounts of tar, nicotine, and other substances that are similar to "regular" cigarettes.

The research and its findings on quitting smoking among switchers are based on almost 31,000 US smokers. In 2003, they answered a questionnaire about whether they had switched to a milder/low tar brand, and their reasons for doing so.

They were also asked if they had attempted to stop smoking altogether during the previous twelve months. They also had to answer whether they had managed to continue.

More than 29,000 people were included in the total sample. They were current smokers and almost 2,000 had given up for at least ninety days.

Overall, 12,000 people (38 percent) had switched to a lighter brand that they perceived would provide a degree of freedom from smoking. One in four cited flavor as the primary reason. Earlier research has indicated that smokers deduce that reductions in flavor strength are reductions in harm from the nicotine side effects.

However, almost one in five (18 percent) said they had switched for a combination of better flavor, wanting to smoke a less harmful cigarette, and the intention of giving up smoking altogether.

In general, 43 percent gave reasons for switching that included a desire to quit smoking altogether. Those who switched brands were 58 percent more likely to have attempted to have stopped smoking between 2002 and 2003 than those who stayed with their brand. But the "switchers" who attempted to quit smoking were in fact 60 percent less likely to be successful.

In addition, those who switched for reasons that included the objective to give up smoking had the lowest chances of actually doing so.

In the whole study group (including those who tried to quit and those who did not) the overall odds of giving up smoking were 46 percent lower among those who switched to a "lighter" cigarette for any reason, than they were among those who remained with their brand.

The authors suggest that despite the apparent greater motivation to give up, switching may in fact establish smoking behavior. This therefore cuts the chances of succeeding.

Another possible explanation is that smokers who find it the most difficult to quit, imagine a lighter brand is better for their health and a good enough smoking alternative to giving up completely.

Cut Down Smoking and Lower Insulin Resistance

Wednesday, October 28, 2009 by John Bancroft

Researchers have discovered another consequence of smoking. Another danger of smoking reason why smoking demonstates that nicotine smoking greatly increases the risk of heart disease and stroke. According to a mouse study, nicotine smoking promotes insulin resistance, also called pre diabetes, which is a risk factor for cardiovascular disease.

People with blood glucose levels that are higher than normal but not yet in the diabetes range have pre diabetes. Insulin resistance and pre diabetes usually have no symptoms and a person could have one or both conditions for several years without noticing anything.

The study results could explain yet another consequence of smoking and why cigarette smokers have a high cardiovascular death rate, even though “smoking causes weight loss, which should protect against heart disease,” said the study’s lead author, Theodore Friedman.

Pre diabetes and diabetes are known risk factors for cardiovascular disease. Past studies show that cigarette smokers tend to be insulin resistant, meaning that their hormone insulin does not work properly. To compensate, their blood glucose (sugar) levels become higher than normal but not yet high enough for diabetes. Smokers also have higher rates of diabetes, but it is not clear whether smoking is the cause, because they could have other risk factors, Friedman explained.

Some studies demonstrate that cigarette and nicotine smoking induce high levels of the stress hormone cortisol. “As cortisol excess is known to induce insulin resistance, it has been suggested that glucocorticoids, such as cortisol, are the missing [causative] link between cigarette smoking and insulin resistance,” Friedman said.

The study results suggest this theory is correct, he said. The researchers studied the effects, on 24 adult mice, of twice-daily injections of nicotine for 2 weeks. The mice ate less food than control mice that received injections without nicotine, and they also lost weight and had less fat. Despite this, the mice receiving nicotine developed pre diabetes (insulin resistance). These mice also had high cortisol levels in their blood and tissues.

Nicotine replacement therapies therefore is not an acceptable product to quit smoking for diabetics.

Diabetics should seek natural alternatives to nicotine gum to help reduce their sensitivity to insulin.


Pregnant smokers: "I tried to quit smoking before..."

Monday, August 10, 2009 by John Bancroft

Number of pregnant smokers on the rise

 

A new report from Flint, Michigan confirms what health professionals around the United States say is one of their toughest challenges: Trying to increase Stop Smoking among pregnant women is on the rise.

 

Last week's new Kids Count report shows the percentage of women who smoked while pregnant rose to 20 percent in 2007. The findings, released Tuesday, were collected by the Annie E. Casey Foundation.

 

Dr. Ivana Vettraino, director of maternal fetal medicine at Hurley Medical Center, is familiar with the smoking problem. She said the best word she can use to describe the numbers who she has counseled to quit smoking is "disappointing."

"When they (patients) look at you and say, 'I've tried to stop smoking before and it hasn't worked,' and then they just walk out, it is a little -- disappointing is the best word I can come up with -- because many of the patients I see have a lot of medical problems. But still, their biggest risk for having a poor pregnancy outcome is their tobacco use resulting from addiction to nicotine ," she said.

 

Potential negative outcomes can include low birth weight, increased risk of cardiovascular and heart disease later in life, and problems with the placenta that could result in early birth or death.  "There's a lot of knowledge now about what happens in utero sort of prognosticates what's going to happen to you later in life," Vettraino said.

 

Smoking --is the leading cause of low birth weight –getting pregnant smokers to quit smoking isn't getting any easier.

 

April Smith, 34, of Flint knows how tough quitting smoking can be. She said that when she was pregnant, she was able to cut back on her smoking the most, but there were "key points" in her day, such as after meals, when she had cravings for tobacco she just couldn't resist.

 

"There's always a battle inside your mind. Yes, you feel bad for doing it, but your craving or nicotine addiction, you feel good," she said. Smith compares quitting smoking to losing weight, saying that if you're not committed to changing your entire life, you're not going to succeed.

 

Trissa Torres, a preventive medicine physician for Genesys Health Systems, started a program at the Genesys Flint East Campus to help pregnant women stop smoking. Within her program, Torres said the majority of people she works with -- all of whom sought help themselves -- know smoking can be dangerous.

 

At Hurley, though, Vettraino said she's surprised by how many patients say they aren't aware of the effects of tobacco can have on an unborn child. And among those who are aware of the risks, she said, the effort to quit smoking often isn't there.

 

"I'm always surprised when there's somebody that tells you they didn't realize the risks. But most of the time they look at you and they nod. They know, and what they tell you is they're really trying hard to quit. Most of them will tell you that they cut down," she said.

 

Vettraino said some expectant mothers quit smoking immediately once they find out they're pregnant, but others, even with the offer of smoking cessation aids such as nicotine patches products to quit smoking, don't make the effort.

 

Even for those mothers who manage to stop smoking, Torres said the larger challenge is staying off cigarettes after children are born. Smith's children are now 8 and 3. She still smokes but said she's cut down, makes a point not to light up around her children and tries to keep them away from other smokers.

 

"I get angry with myself because it's ridiculous. ... Some days I can go all day without smoking, but the next day I make up for it. It's ridiculous," she said. "I regret it."

Reprinted and Exerpted
Scott Atkinson | The Flint Journal

Monday August 03, 2009,

Nicotine Gum, Lozenges Could Cause Oral Cancer

Friday, July 17, 2009 by John Bancroft

 

Researchers say that there is no doubt that nicotine gum, nicotine lozenges are products to quit smoking but would you use them as part of your stop smoking program if you knew they could cause oral cancers.

Now new genetic research from the U.K.'s Medical Research Council suggests that nicotine-replacement drugs like nicotine gum and lozenges when used to stop smoking could raise the risk of mouth cancer, Medical News Today reported on April 26.

Researcher Muy-Teck Teh of the Institute of Dentistry, Barts and the London School of Medicine and Dentistry at Queen Mary University London said that nicotine appears to increase expression of the gene FOXM1 in the mouth; increased levels of the gene is known to be associated with some forms of cancer.

 "Our study found that FOXM1 was enhanced during the early progressive stages of mouth cancer. This means if someone has increased levels of FOXM1 in their mouth, it could indicate the early stages of mouth cancer," said Teh. "We were surprised to find that nicotine increased the levels of FOXM1 in the cells. We used the same amount of nicotine found in nicotine  replacement therapies such as chewing gums and the amount was enough to activate the gene."

Most mouth cancers are caused by smoking, chewing tobacco, and/or drinking alcohol. Although several recent studies seem to confirm nicotine is mutagenic, it has not previously been considered to be a carcinogen.

"Although we acknowledge the importance of encouraging people to quit smoking, our research suggests nicotine found in lozenges and chewing gums may increase the risk of mouth cancer," Teh said.

This
research published online in the journal PLos One may cause those smokers seeking the best way to to quit smoking to look for more natural stop smoking alternatives which are easily found by searching the internet.

FDA Issues Suicide Warnings on the Stop Smoking Drugs Chantix, Zyban

Saturday, July 11, 2009 by John Bancroft

FDA Issues Suicide Warnings on the Stop Smoking Drugs Chantix, Zyban

Patients seeking products to quit smoking should think twice when taking the stop-smoking drugs Chantix and Zyban/Wellbutrin. They should be closely monitored for symptoms of serious mental illness that could lead to the risk of suicide, according to a new directive from the U.S. Food and Drug Administration (FDA).

The New York Times New reported July 2 that FDA officials stressed that patients should not be discouraged from taking the drugs to quit smoking. "Stopping smoking is a goal we should all be working towards," said FDA official Curtis J. Rosebraugh. "We don't want to scare people off from trying a medication that could help them to find alternatives in their fight to quit smoking. But they should just be careful."

FDA announced plans to add a stronger warning to Chantix packaging, and drug maker Glaxo will add the warnings currently on Wellbutrin to Zyban -- both formulations of the drug buproprion.

Sales of smoking-cessation drugs have declined in recent years. Chantix, made by Pfizer, controls about 90 percent of the quit smoking drug market, with $846 million in annual sales. Still, the drug has fallen short of sales expectations, in part because of prior safety concerns.

CHEERS to another big pharmaceutical whose sole mission in helping smokers to quit smoking and find freedom from smoking is greed and making a profit.


Nicotine Withdrawal and Cravings

Friday, May 29, 2009 by John Bancroft

Researchers from Duke University Medical Center Duke have used brain PET scans to identify three regions of the brain that seem to control nicotine dependence and craving.

The affected regions include the thalamus, which controls sensory input and may be related to the inability to focus and feeling of being overwhelmed often experienced during withdrawal; the straitum, also know as the brain's pleasure center; and the anterior cingulate cortex, which is involved in cognitive functions like conflict resolution, self-regulation, decision making, and emotion.

All combined they demonstrate why the cravings for cigarettes and tobacco products makes quitting smoking difficult.

"If you can't calm down, can't derive pleasure and can't control yourself or concentrate, then it will be extremely difficult for you to break the habit," said lead study researcher Jed E. Rose, Ph.D., director of the Duke Center for Nicotine and Smoking Cessation Research. "These brain regions may explain why most people try to quit several times before they are successful."

Preparation is necessary to quit smoking to avoid relapse than can be attributed to cravings. It is best to take a measured approach and look for those alternatives that can help you at the times when cravings are strongest amd make you want to smoke when you dont want to smoke or cant. Make a choice in those moments

The study was published online in the journal "Neuropsychopharmacology".